Rupatadine Fumarate from Canada
Rupatadine fumarate is a dual antihistamine/PAF antagonist with nitrogen-heterocyclic and aromatic components. It qualifies as an antihistamine drug under HTS 2933.99.26.00 per chapter notes on salts.
Duty Rate — Canada → United States
110%
Rate breakdown
9903.04.6093.5%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.2910%Except for products described in headings 9903.05.85–9903.05.93, articles the product of Canada, as provided for in U.S. note 52 to this subchapter
Import Tips
• Classify fumarate salt with the organic base per chapter note on salts
• Provide counterion balance analysis for salt stoichiometry
• Ensure polymorphic form consistency with DMF specifications